Kodiak Sciences, Inc. (KOD)
98.39
-0.87
(-0.88%)
USD |
NASDAQ |
Oct 13, 11:43
Kodiak Sciences Net Income (TTM) : -241.99M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -241.99M |
| March 31, 2026 | -230.66M |
| December 31, 2025 | -229.97M |
| September 30, 2025 | -217.34M |
| June 30, 2025 | -199.82M |
| March 31, 2025 | -190.63M |
| December 31, 2024 | -176.21M |
| September 30, 2024 | -191.62M |
| June 30, 2024 | -197.68M |
| March 31, 2024 | -232.75M |
| December 31, 2023 | -260.49M |
| September 30, 2023 | -271.42M |
| June 30, 2023 | -298.45M |
| March 31, 2023 | -308.89M |
| December 31, 2022 | -333.82M |
| September 30, 2022 | -356.54M |
| Date | Value |
|---|---|
| June 30, 2022 | -347.03M |
| March 31, 2022 | -312.25M |
| December 31, 2021 | -266.99M |
| September 30, 2021 | -220.41M |
| June 30, 2021 | -189.00M |
| March 31, 2021 | -159.15M |
| December 31, 2020 | -133.10M |
| September 30, 2020 | -102.13M |
| June 30, 2020 | -78.39M |
| March 31, 2020 | -63.77M |
| December 31, 2019 | -47.36M |
| September 30, 2019 | -46.41M |
| June 30, 2019 | -44.48M |
| March 31, 2019 | -42.02M |
| December 31, 2018 | -45.60M |
| September 30, 2018 | -35.52M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.329B |
| AbbVie, Inc. | 6.274B |
| Mirum Pharmaceuticals, Inc. | -860.21M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |